MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹2,196 Cr | ₹1,727 Cr | ₹1,473 Cr | ₹1,334 Cr | ₹845 Cr |
What is the latest Net Current Assets ratio of MARKSANS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹2,196 Cr |
| Mar2025 | ₹1,727 Cr |
| Mar2024 | ₹1,473 Cr |
| Mar2023 | ₹1,334 Cr |
| Mar2022 | ₹845 Cr |
How is Net Current Assets of MARKSANS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,196 Cr | 27.15 | |
| Mar2025 | ₹1,727 Cr | 17.26 | |
| Mar2024 | ₹1,473 Cr | 10.37 | |
| Mar2023 | ₹1,334 Cr | 57.91 | |
| Mar2022 | ₹845 Cr | - | |
Compare Net Current Assets of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,008.4 Cr | 0.2% | 0.4% | 63.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 0.2% |
0.4% |
63.8% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses